Hillsdale Investment Management’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Hillsdale Investment Management’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-900	Closed	-$41K	–	596
2015 Q1	$41K	Buy	+900	New	+$26.9K	0.01%	448

Hillsdale Investment Management's HPTX Position: Q2 2015 in Review

Hillsdale Investment Management sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 900 shares — an estimated $41K sold.

Hillsdale Investment Management first reported a position in HPTX in Q1 2015 and held it in 1 quarter. The position peaked at $41K in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

Hillsdale Investment Management reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Hillsdale Investment Management sold 900 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $41K.
Hillsdale Investment Management first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
Hillsdale Investment Management's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $41K in Q1 2015.
0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Hillsdale Investment Management's 13F filing for Q2 2015, filed 26 Aug 2015.